SKI Market

Indian Indices

Nifty

25,492.30 -17.40
(-0.07%)

Sensex

83,216.28 -94.73
( -0.11%)

Bank Nifty

57,876.80 322.55
( 0.56%)

Nifty IT

35,117.65 -219.95
( -0.62%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,211.07 -672.61
(-1.32%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.65 -0.03
(-0.04%)

EUR-INR

101.82 -0.15
(-0.14%)

GBP-INR

115.54 -0.38
(-0.33%)

JPY-INR

0.58 0.00
(-0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

27.05

31279.01

EPS(TTM)

Face Value()

Div & Yield %

70.19

0.95

Back

manbro industries ltd

APL Apollo Tubes consolidated net profit rises 460.38% in the September 2025 quarter

Oct 29,2025

Net profit of APL Apollo Tubes rose 460.38% to Rs 301.54 crore in the quarter ended September 2025 as against Rs 53.81 crore during the previous quarter ended September 2024. Sales rose 8.86% to Rs 5037.66 crore in the quarter ended September 2025 as against Rs 4627.80 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5037.66	4627.80	9
OPM %	8.87	2.98	-
PBDT	444.49	116.47	282
PBT	386.36	69.59	455
NP	301.54	53.81	460

25,492.30 -17.40 (-0.07%)

83,216.28 -94.73 ( -0.11%)

57,876.80 322.55 ( 0.56%)

35,117.65 -219.95 ( -0.62%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,211.07 -672.61 (-1.32%)

9,736.38 -40.70 (-0.42%)

88.65 -0.03 (-0.04%)

101.82 -0.15 (-0.14%)

115.54 -0.38 (-0.33%)

0.58 0.00 (-0.08%)